{
  "timestamp": "20250610_101545",
  "evaluation_duration": 1001.7074780464172,
  "pipeline_results": {
    "BasicRAG": [
      {
        "question": "What are the effects of metformin on type 2 diabetes?",
        "answer": "[Document(page_content='67', metadata={}, id='2297'), Document(page_content='68', metadata={}, id='2458'), Document(page_content='87', metadata={}, id='3292'), Document(page_content='71', metadata={}, id='2915'), Document(page_content='76', metadata={}, id='2674')]",
        "contexts": [],
        "ground_truth": "Metformin helps treat type 2 diabetes by reducing glucose production in the liver and increasing insulin sensitivity in peripheral tissues.",
        "execution_time": 0.12566018104553223,
        "success": true,
        "error": null
      },
      {
        "question": "How does SGLT2 inhibition affect kidney function?",
        "answer": "[Document(page_content='73', metadata={}, id='2624'), Document(page_content='73', metadata={}, id='2914'), Document(page_content='73', metadata={}, id='2759'), Document(page_content='73', metadata={}, id='3201'), Document(page_content='73', metadata={}, id='2875')]",
        "contexts": [],
        "ground_truth": "SGLT2 inhibitors protect kidney function by reducing hyperfiltration, decreasing albuminuria, and providing nephroprotection through mechanisms independent of glycemic control.",
        "execution_time": 0.05110502243041992,
        "success": true,
        "error": null
      },
      {
        "question": "What is the mechanism of action of GLP-1 receptor agonists?",
        "answer": "[Document(page_content='71', metadata={}, id='2915'), Document(page_content='84', metadata={}, id='3107'), Document(page_content='71', metadata={}, id='3061'), Document(page_content='73', metadata={}, id='2875'), Document(page_content='78', metadata={}, id='2519')]",
        "contexts": [],
        "ground_truth": "GLP-1 receptor agonists work by stimulating insulin secretion, suppressing glucagon secretion, slowing gastric emptying, and promoting satiety, ultimately improving glycemic control and often leading to weight loss.",
        "execution_time": 0.05477786064147949,
        "success": true,
        "error": null
      }
    ],
    "HyDERAG": [
      {
        "question": "What are the effects of metformin on type 2 diabetes?",
        "answer": "Metformin is a commonly prescribed medication for the management of type 2 diabetes. Its primary effects include:\n\n1. **Lowering Blood Sugar Levels**: Metformin helps to reduce blood glucose levels by decreasing hepatic glucose production, particularly in the liver.\n\n2. **Improving Insulin Sensitivity**: It enhances the sensitivity of muscle cells to insulin, which helps the body use glucose more effectively.\n\n3. **Weight Management**: Metformin is associated with weight loss or weight stabilization, which can be beneficial for individuals with type 2 diabetes who are overweight or obese.\n\n4. **Reducing Cardiovascular Risk**: Some studies suggest that metformin may have cardiovascular benefits, potentially reducing the risk of heart disease in people with type 2 diabetes.\n\n5. **Decreasing Gastrointestinal Absorption of Glucose**: Metformin may also reduce the absorption of glucose from the gastrointestinal tract.\n\n6. **Potential Anti-inflammatory Effects**: There is evidence that metformin may have anti-inflammatory properties, which can be beneficial in managing diabetes-related complications.\n\nOverall, metformin is an effective first-line treatment for type 2 diabetes, helping to control blood sugar levels and improve metabolic health.",
        "contexts": [
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]"
        ],
        "ground_truth": "Metformin helps treat type 2 diabetes by reducing glucose production in the liver and increasing insulin sensitivity in peripheral tissues.",
        "execution_time": 70.38318061828613,
        "success": true,
        "error": null
      },
      {
        "question": "How does SGLT2 inhibition affect kidney function?",
        "answer": "SGLT2 (Sodium-Glucose Cotransporter 2) inhibition has several effects on kidney function, primarily beneficial in the context of diabetes and heart failure. Here are the key points regarding its impact:\n\n1. **Glucose Excretion**: SGLT2 inhibitors promote the excretion of glucose in the urine, which helps lower blood glucose levels. This is particularly beneficial for patients with type 2 diabetes.\n\n2. **Diuretic Effect**: By inhibiting SGLT2, these medications also have a mild diuretic effect, leading to increased urine output. This can help reduce fluid overload in patients with heart failure or chronic kidney disease.\n\n3. **Renal Hemodynamics**: SGLT2 inhibitors can improve renal hemodynamics by reducing intraglomerular pressure. This is achieved through the reduction of sodium reabsorption in the proximal tubule, leading to a decrease in hyperfiltration, which is often seen in diabetic nephropathy.\n\n4. **Cardiorenal Protection**: Clinical studies have shown that SGLT2 inhibitors can provide protective effects on the kidneys, slowing the progression of kidney disease in diabetic patients. They have been associated with a reduction in the risk of kidney failure and cardiovascular events.\n\n5. **Metabolic Effects**: These inhibitors may also have favorable effects on weight and blood pressure, which can indirectly benefit kidney function.\n\nOverall, SGLT2 inhibition is associated with improved kidney function and protection against the progression of kidney disease, particularly in patients with diabetes.",
        "contexts": [
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]"
        ],
        "ground_truth": "SGLT2 inhibitors protect kidney function by reducing hyperfiltration, decreasing albuminuria, and providing nephroprotection through mechanisms independent of glycemic control.",
        "execution_time": 84.47692608833313,
        "success": true,
        "error": null
      },
      {
        "question": "What is the mechanism of action of GLP-1 receptor agonists?",
        "answer": "GLP-1 receptor agonists are a class of medications that mimic the action of the glucagon-like peptide-1 (GLP-1), a hormone that plays a key role in glucose metabolism. Their mechanism of action includes the following key effects:\n\n1. **Stimulating Insulin Secretion**: GLP-1 receptor agonists enhance insulin secretion from the pancreas in response to meals, which helps lower blood glucose levels.\n\n2. **Inhibiting Glucagon Release**: They reduce the secretion of glucagon, a hormone that raises blood glucose levels, thereby contributing to better glycemic control.\n\n3. **Slowing Gastric Emptying**: These medications slow down the rate at which food leaves the stomach, which helps to reduce postprandial (after meal) blood sugar spikes.\n\n4. **Promoting Satiety**: GLP-1 receptor agonists increase feelings of fullness, which can lead to reduced food intake and weight loss.\n\n5. **Cardiovascular Benefits**: Some GLP-1 receptor agonists have been shown to have cardiovascular protective effects, reducing the risk of major adverse cardiovascular events in patients with type 2 diabetes.\n\nOverall, GLP-1 receptor agonists help to improve glycemic control and can also aid in weight management for individuals with type 2 diabetes.",
        "contexts": [
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]"
        ],
        "ground_truth": "GLP-1 receptor agonists work by stimulating insulin secretion, suppressing glucagon secretion, slowing gastric emptying, and promoting satiety, ultimately improving glycemic control and often leading to weight loss.",
        "execution_time": 71.35578989982605,
        "success": true,
        "error": null
      }
    ],
    "CRAG": [
      {
        "question": "What are the effects of metformin on type 2 diabetes?",
        "answer": "[Document(page_content='67', metadata={'similarity_score': 0.6785211563110352, 'retrieval_method': 'initial_vector_similarity'}, id='sample'), Document(page_content='68', metadata={'similarity_score': 0.5278230309486389, 'retrieval_method': 'initial_vector_similarity'}, id='PMC1748704577'), Document(page_content='87', metadata={'similarity_score': 0.4415596127510071, 'retrieval_method': 'initial_vector_similarity'}, id='PMC11650328'), Document(page_content='71', metadata={'similarity_score': 0.43702104687690735, 'retrieval_method': 'initial_vector_similarity'}, id='PMC11630531'), Document(page_content='76', metadata={'similarity_score': 0.43200013041496277, 'retrieval_method': 'initial_vector_similarity'}, id='PMC11651687')]",
        "contexts": [],
        "ground_truth": "Metformin helps treat type 2 diabetes by reducing glucose production in the liver and increasing insulin sensitivity in peripheral tissues.",
        "execution_time": 0.0548098087310791,
        "success": true,
        "error": null
      },
      {
        "question": "How does SGLT2 inhibition affect kidney function?",
        "answer": "[Document(page_content='73', metadata={'similarity_score': 0.537039041519165, 'retrieval_method': 'initial_vector_similarity'}, id='PMC1748704682')]",
        "contexts": [],
        "ground_truth": "SGLT2 inhibitors protect kidney function by reducing hyperfiltration, decreasing albuminuria, and providing nephroprotection through mechanisms independent of glycemic control.",
        "execution_time": 0.03340911865234375,
        "success": true,
        "error": null
      },
      {
        "question": "What is the mechanism of action of GLP-1 receptor agonists?",
        "answer": "[Document(page_content='71', metadata={'similarity_score': 0.5381851196289062, 'retrieval_method': 'knowledge_base_expansion'}, id='PMC11630531'), Document(page_content='84', metadata={'similarity_score': 0.36178669333457947, 'retrieval_method': 'knowledge_base_expansion'}, id='PMC11649812'), Document(page_content='71', metadata={'similarity_score': 0.32712316513061523, 'retrieval_method': 'knowledge_base_expansion'}, id='PMC11649813'), Document(page_content='73', metadata={'similarity_score': 0.3120233118534088, 'retrieval_method': 'knowledge_base_expansion'}, id='PMC11344719'), Document(page_content='78', metadata={'similarity_score': 0.2971397936344147, 'retrieval_method': 'knowledge_base_expansion'}, id='PMC1748704639')]",
        "contexts": [],
        "ground_truth": "GLP-1 receptor agonists work by stimulating insulin secretion, suppressing glucagon secretion, slowing gastric emptying, and promoting satiety, ultimately improving glycemic control and often leading to weight loss.",
        "execution_time": 0.034380197525024414,
        "success": true,
        "error": null
      }
    ],
    "ColBERTRAG": [
      {
        "question": "What are the effects of metformin on type 2 diabetes?",
        "answer": "[]",
        "contexts": [],
        "ground_truth": "Metformin helps treat type 2 diabetes by reducing glucose production in the liver and increasing insulin sensitivity in peripheral tissues.",
        "execution_time": 0.020817995071411133,
        "success": true,
        "error": null
      },
      {
        "question": "How does SGLT2 inhibition affect kidney function?",
        "answer": "[]",
        "contexts": [],
        "ground_truth": "SGLT2 inhibitors protect kidney function by reducing hyperfiltration, decreasing albuminuria, and providing nephroprotection through mechanisms independent of glycemic control.",
        "execution_time": 0.019559860229492188,
        "success": true,
        "error": null
      },
      {
        "question": "What is the mechanism of action of GLP-1 receptor agonists?",
        "answer": "[]",
        "contexts": [],
        "ground_truth": "GLP-1 receptor agonists work by stimulating insulin secretion, suppressing glucagon secretion, slowing gastric emptying, and promoting satiety, ultimately improving glycemic control and often leading to weight loss.",
        "execution_time": 0.019663095474243164,
        "success": true,
        "error": null
      }
    ],
    "NodeRAG": [
      {
        "question": "What are the effects of metformin on type 2 diabetes?",
        "answer": "[]",
        "contexts": [],
        "ground_truth": "Metformin helps treat type 2 diabetes by reducing glucose production in the liver and increasing insulin sensitivity in peripheral tissues.",
        "execution_time": 0.02477407455444336,
        "success": true,
        "error": null
      },
      {
        "question": "How does SGLT2 inhibition affect kidney function?",
        "answer": "[]",
        "contexts": [],
        "ground_truth": "SGLT2 inhibitors protect kidney function by reducing hyperfiltration, decreasing albuminuria, and providing nephroprotection through mechanisms independent of glycemic control.",
        "execution_time": 0.027229785919189453,
        "success": true,
        "error": null
      },
      {
        "question": "What is the mechanism of action of GLP-1 receptor agonists?",
        "answer": "[]",
        "contexts": [],
        "ground_truth": "GLP-1 receptor agonists work by stimulating insulin secretion, suppressing glucagon secretion, slowing gastric emptying, and promoting satiety, ultimately improving glycemic control and often leading to weight loss.",
        "execution_time": 0.0263979434967041,
        "success": true,
        "error": null
      }
    ],
    "GraphRAG": [
      {
        "question": "What are the effects of metformin on type 2 diabetes?",
        "answer": "Metformin is a widely used medication for the management of type 2 diabetes. Its primary effects include:\n\n1. **Lowering Blood Sugar Levels**: Metformin helps to reduce blood glucose levels by decreasing hepatic glucose production and increasing insulin sensitivity in peripheral tissues.\n\n2. **Weight Management**: Unlike some other diabetes medications, metformin is associated with weight loss or weight neutrality, making it a preferred option for overweight or obese patients with type 2 diabetes.\n\n3. **Improving Lipid Profiles**: Metformin can lead to improvements in lipid levels, including reductions in triglycerides and LDL cholesterol, which are beneficial for cardiovascular health.\n\n4. **Reducing the Risk of Complications**: Long-term use of metformin has been associated with a reduced risk of diabetes-related complications, such as cardiovascular disease.\n\n5. **Potential Benefits Beyond Diabetes**: Some studies suggest that metformin may have additional benefits, such as potential anti-cancer effects and improvements in polycystic ovary syndrome (PCOS).\n\nOverall, metformin is considered a first-line treatment for type 2 diabetes due to its efficacy, safety profile, and additional health benefits.",
        "contexts": [
          "67",
          "68",
          "87",
          "71",
          "76"
        ],
        "ground_truth": "Metformin helps treat type 2 diabetes by reducing glucose production in the liver and increasing insulin sensitivity in peripheral tissues.",
        "execution_time": 29.752274990081787,
        "success": true,
        "error": null
      },
      {
        "question": "How does SGLT2 inhibition affect kidney function?",
        "answer": "SGLT2 inhibition has been shown to have beneficial effects on kidney function. It primarily works by reducing glucose reabsorption in the kidneys, leading to increased glucose excretion and a reduction in blood glucose levels. This mechanism not only helps in managing diabetes but also has protective effects on the kidneys.\n\nStudies indicate that SGLT2 inhibitors can lead to improvements in kidney outcomes, including a reduction in the progression of chronic kidney disease (CKD) and a decrease in the risk of kidney failure. They may also help in reducing albuminuria, which is a marker of kidney damage. Additionally, SGLT2 inhibitors can promote diuresis, leading to a reduction in intraglomerular pressure, which can further protect kidney function.\n\nOverall, SGLT2 inhibition is associated with improved kidney function and reduced risk of adverse kidney-related outcomes in patients with diabetes and other kidney conditions.",
        "contexts": [
          "73",
          "73",
          "73",
          "73",
          "80"
        ],
        "ground_truth": "SGLT2 inhibitors protect kidney function by reducing hyperfiltration, decreasing albuminuria, and providing nephroprotection through mechanisms independent of glycemic control.",
        "execution_time": 23.175697088241577,
        "success": true,
        "error": null
      },
      {
        "question": "What is the mechanism of action of GLP-1 receptor agonists?",
        "answer": "GLP-1 receptor agonists work by mimicking the action of the glucagon-like peptide-1 (GLP-1), a hormone that is involved in glucose metabolism. Their mechanism of action includes:\n\n1. **Stimulating Insulin Secretion**: They enhance glucose-dependent insulin secretion from the pancreas, meaning they promote insulin release when blood sugar levels are elevated.\n\n2. **Inhibiting Glucagon Secretion**: GLP-1 receptor agonists reduce the secretion of glucagon, a hormone that raises blood sugar levels, thereby helping to lower blood glucose.\n\n3. **Slowing Gastric Emptying**: They slow down the rate at which food leaves the stomach, which helps to reduce postprandial (after meal) blood sugar spikes.\n\n4. **Promoting Satiety**: These agonists can increase feelings of fullness, which may help reduce food intake and support weight loss.\n\nOverall, GLP-1 receptor agonists are used primarily in the treatment of type 2 diabetes and can also aid in weight management.",
        "contexts": [
          "71",
          "84",
          "71",
          "68",
          "67"
        ],
        "ground_truth": "GLP-1 receptor agonists work by stimulating insulin secretion, suppressing glucagon secretion, slowing gastric emptying, and promoting satiety, ultimately improving glycemic control and often leading to weight loss.",
        "execution_time": 23.689999103546143,
        "success": true,
        "error": null
      }
    ],
    "HybridIFindRAG": [
      {
        "question": "What are the effects of metformin on type 2 diabetes?",
        "answer": "Metformin is a widely used medication for the management of type 2 diabetes. Its primary effects include:\n\n1. **Lowering Blood Sugar Levels**: Metformin helps to reduce blood glucose levels by decreasing hepatic glucose production, particularly in the liver, and improving insulin sensitivity in peripheral tissues.\n\n2. **Weight Management**: Unlike some other diabetes medications, metformin is associated with weight loss or weight neutrality, making it a preferred option for overweight or obese patients with type 2 diabetes.\n\n3. **Cardiovascular Benefits**: Studies suggest that metformin may have cardiovascular protective effects, reducing the risk of heart disease in patients with type 2 diabetes.\n\n4. **Improving Lipid Profiles**: Metformin can help improve lipid levels, including lowering triglycerides and LDL cholesterol, which are often elevated in individuals with type 2 diabetes.\n\n5. **Potential Cancer Risk Reduction**: Some research indicates that metformin may be associated with a reduced risk of certain types of cancer, although more studies are needed to confirm this effect.\n\n6. **Gastrointestinal Side Effects**: Common side effects of metformin include gastrointestinal issues such as nausea, diarrhea, and abdominal discomfort, especially when starting the medication or increasing the dose.\n\nOverall, metformin is considered a first-line treatment for type 2 diabetes due to its efficacy, safety profile, and additional health benefits.",
        "contexts": [
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]"
        ],
        "ground_truth": "Metformin helps treat type 2 diabetes by reducing glucose production in the liver and increasing insulin sensitivity in peripheral tissues.",
        "execution_time": 23.433475255966187,
        "success": true,
        "error": null
      },
      {
        "question": "How does SGLT2 inhibition affect kidney function?",
        "answer": "SGLT2 (Sodium-Glucose Cotransporter 2) inhibition has several effects on kidney function, primarily through its role in glucose and sodium reabsorption in the renal tubules. Here are the key effects:\n\n1. **Increased Glucose Excretion**: SGLT2 inhibitors prevent the reabsorption of glucose in the proximal tubule of the kidney, leading to increased glucose excretion in the urine. This can help lower blood glucose levels in patients with diabetes.\n\n2. **Diuretic Effect**: By inhibiting glucose reabsorption, SGLT2 inhibitors also promote osmotic diuresis, which can lead to increased urine output and reduced fluid overload. This can be beneficial in patients with heart failure or chronic kidney disease (CKD).\n\n3. **Renal Hemodynamics**: SGLT2 inhibitors can improve renal hemodynamics by reducing intraglomerular pressure. This is thought to occur through a reduction in sodium reabsorption, which leads to a decrease in the workload of the kidneys and may help protect against kidney damage.\n\n4. **Cardiorenal Protection**: Clinical studies have shown that SGLT2 inhibitors can provide protective effects on the kidneys, reducing the progression of CKD and the risk of cardiovascular events in patients with diabetes and other risk factors.\n\n5. **Potential for Acute Kidney Injury**: While SGLT2 inhibitors are generally well-tolerated, there is a potential risk for acute kidney injury, particularly in patients with pre-existing renal impairment or those who are volume-depleted.\n\nOverall, SGLT2 inhibition can have beneficial effects on kidney function, particularly in diabetic patients, by improving glycemic control, promoting diuresis, and providing renal protection. However, careful monitoring is necessary to mitigate any risks associated with their use.",
        "contexts": [
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]"
        ],
        "ground_truth": "SGLT2 inhibitors protect kidney function by reducing hyperfiltration, decreasing albuminuria, and providing nephroprotection through mechanisms independent of glycemic control.",
        "execution_time": 31.273096799850464,
        "success": true,
        "error": null
      },
      {
        "question": "What is the mechanism of action of GLP-1 receptor agonists?",
        "answer": "GLP-1 receptor agonists are a class of medications that mimic the action of the glucagon-like peptide-1 (GLP-1), a hormone that plays a key role in glucose metabolism. Their mechanism of action includes the following key effects:\n\n1. **Stimulating Insulin Secretion**: GLP-1 receptor agonists enhance the secretion of insulin from the pancreas in response to meals, particularly when blood glucose levels are elevated.\n\n2. **Inhibiting Glucagon Release**: They reduce the secretion of glucagon, a hormone that raises blood glucose levels, thereby helping to lower blood sugar.\n\n3. **Slowing Gastric Emptying**: These medications slow down the rate at which food leaves the stomach, which helps to reduce postprandial (after meal) blood sugar spikes.\n\n4. **Promoting Satiety**: GLP-1 receptor agonists increase feelings of fullness, which can lead to reduced food intake and weight loss.\n\n5. **Cardiovascular Benefits**: Some GLP-1 receptor agonists have been shown to have cardiovascular protective effects, reducing the risk of major adverse cardiovascular events in patients with type 2 diabetes.\n\nOverall, GLP-1 receptor agonists help to improve glycemic control and can aid in weight management for individuals with type 2 diabetes.",
        "contexts": [
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]",
          "[Error Reading Streamed dict content]"
        ],
        "ground_truth": "GLP-1 receptor agonists work by stimulating insulin secretion, suppressing glucagon secretion, slowing gastric emptying, and promoting satiety, ultimately improving glycemic control and often leading to weight loss.",
        "execution_time": 22.416683197021484,
        "success": true,
        "error": null
      }
    ]
  },
  "ragas_results": {
    "BasicRAG": {
      "answer_relevancy": 0.05972916963729826,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "faithfulness": 0.0,
      "answer_similarity": null,
      "answer_correctness": NaN
    },
    "HyDERAG": {
      "answer_relevancy": 0.8819285196880974,
      "context_precision": NaN,
      "context_recall": 0.0,
      "faithfulness": 0.3333333333333333,
      "answer_similarity": null,
      "answer_correctness": NaN
    },
    "CRAG": {
      "answer_relevancy": 0.025292599341854852,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "faithfulness": 0.0,
      "answer_similarity": null,
      "answer_correctness": NaN
    },
    "ColBERTRAG": {
      "answer_relevancy": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "faithfulness": NaN,
      "answer_similarity": null,
      "answer_correctness": NaN
    },
    "NodeRAG": {
      "answer_relevancy": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "faithfulness": NaN,
      "answer_similarity": null,
      "answer_correctness": 0.017545003695557067
    },
    "GraphRAG": {
      "answer_relevancy": 0.8944920511895393,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "faithfulness": 0.0,
      "answer_similarity": null,
      "answer_correctness": NaN
    },
    "HybridIFindRAG": {
      "answer_relevancy": 0.8785026246658187,
      "context_precision": NaN,
      "context_recall": 0.0,
      "faithfulness": 0.3333333333333333,
      "answer_similarity": null,
      "answer_correctness": 0.4130885663804878
    }
  }
}